Researchers develop a dual NLRP1 and NLRP3 inflammasome inhibitor, a novel class of anti-inflammatory drug
A new class of anti-inflammatory drug is opening a world of possibilities for treating everything from neurological diseases to cancers.
Jul 6, 2023
0
14